356 related articles for article (PubMed ID: 24928173)
1. The in vitro and in vivo profile of aclidinium bromide in comparison with glycopyrronium bromide.
Gavaldà A; Ramos I; Carcasona C; Calama E; Otal R; Montero JL; Sentellas S; Aparici M; Vilella D; Alberti J; Beleta J; Miralpeix M
Pulm Pharmacol Ther; 2014 Aug; 28(2):114-21. PubMed ID: 24928173
[TBL] [Abstract][Full Text] [Related]
2. Characterization of aclidinium bromide, a novel inhaled muscarinic antagonist, with long duration of action and a favorable pharmacological profile.
Gavaldà A; Miralpeix M; Ramos I; Otal R; Carreño C; Viñals M; Doménech T; Carcasona C; Reyes B; Vilella D; Gras J; Cortijo J; Morcillo E; Llenas J; Ryder H; Beleta J
J Pharmacol Exp Ther; 2009 Nov; 331(2):740-51. PubMed ID: 19710368
[TBL] [Abstract][Full Text] [Related]
3. The Influence of receptor kinetics on the onset and duration of action and the therapeutic index of NVA237 and tiotropium.
Sykes DA; Dowling MR; Leighton-Davies J; Kent TC; Fawcett L; Renard E; Trifilieff A; Charlton SJ
J Pharmacol Exp Ther; 2012 Nov; 343(2):520-8. PubMed ID: 22854200
[TBL] [Abstract][Full Text] [Related]
4. Aclidinium bromide, a new, long-acting, inhaled muscarinic antagonist: in vitro plasma inactivation and pharmacological activity of its main metabolites.
Sentellas S; Ramos I; Albertí J; Salvà M; Antón F; Miralpeix M; Beleta J; Gavaldà A
Eur J Pharm Sci; 2010 Mar; 39(5):283-90. PubMed ID: 20093184
[TBL] [Abstract][Full Text] [Related]
5. Pharmacological assessment of the onset of action of aclidinium and glycopyrronium versus tiotropium in COPD patients and human isolated bronchi.
Rogliani P; Calzetta L; Ora J; Lipsi R; Segreti A; Matera MG; Cazzola M
Eur J Pharmacol; 2015 Aug; 761():383-90. PubMed ID: 25952728
[TBL] [Abstract][Full Text] [Related]
6. Comparing the cardiovascular therapeutic indices of glycopyrronium and tiotropium in an integrated rat pharmacokinetic, pharmacodynamic and safety model.
Trifilieff A; Ethell BT; Sykes DA; Watson KJ; Collingwood S; Charlton SJ; Kent TC
Toxicol Appl Pharmacol; 2015 Aug; 287(1):9-16. PubMed ID: 26026369
[TBL] [Abstract][Full Text] [Related]
7. Aclidinium bromide, a novel long-acting muscarinic antagonist for COPD with improved preclinical renal and urinary safety profile.
Gavaldà A; Gras J; Llupià J; Aubets J; Beleta J; Llenas J
Life Sci; 2012 Feb; 90(7-8):301-5. PubMed ID: 22213116
[TBL] [Abstract][Full Text] [Related]
8. Pharmacological assessment of the duration of action of glycopyrrolate vs tiotropium and ipratropium in guinea-pig and human airways.
Villetti G; Bergamaschi M; Bassani F; Bolzoni PT; Harrison S; Gigli PM; Janni A; Geppetti P; Civelli M; Patacchini R
Br J Pharmacol; 2006 Jun; 148(3):291-8. PubMed ID: 16565730
[TBL] [Abstract][Full Text] [Related]
9. Comparative efficacy of aclidinium versus glycopyrronium and tiotropium, as maintenance treatment of moderate to severe COPD patients: a systematic review and network meta-analysis.
Karabis A; Lindner L; Mocarski M; Huisman E; Greening A
Int J Chron Obstruct Pulmon Dis; 2013; 8():405-23. PubMed ID: 24043936
[TBL] [Abstract][Full Text] [Related]
10. The potential for aclidinium bromide, a new anticholinergic, in the management of chronic obstructive pulmonary disease.
Maltais F; Milot J
Ther Adv Respir Dis; 2012 Dec; 6(6):345-61. PubMed ID: 23075544
[TBL] [Abstract][Full Text] [Related]
11. In vivo pharmacological characterization of TD-4208, a novel lung-selective inhaled muscarinic antagonist with sustained bronchoprotective effect in experimental animal models.
Pulido-Rios MT; McNamara A; Obedencio GP; Ji Y; Jaw-Tsai S; Martin WJ; Hegde SS
J Pharmacol Exp Ther; 2013 Aug; 346(2):241-50. PubMed ID: 23685545
[TBL] [Abstract][Full Text] [Related]
12. Bronchodilator activity of (3R)-3-[[[(3-fluorophenyl)[(3,4,5-trifluorophenyl)methyl]amino] carbonyl]oxy]-1-[2-oxo-2-(2-thienyl)ethyl]-1-azoniabicyclo[2.2.2]octane bromide (CHF5407), a potent, long-acting, and selective muscarinic M3 receptor antagonist.
Villetti G; Pastore F; Bergamaschi M; Bassani F; Bolzoni PT; Battipaglia L; Amari G; Rizzi A; Delcanale M; Volta R; Cenacchi V; Cacciani F; Zaniboni M; Berti F; Rossoni G; Harrison S; Petrillo P; Santoro E; Scudellaro R; Mannini F; Geppetti PA; Razzetti R; Patacchini R; Civelli M
J Pharmacol Exp Ther; 2010 Dec; 335(3):622-35. PubMed ID: 20805306
[TBL] [Abstract][Full Text] [Related]
13. Tiotropium bromide (Ba 679 BR), a novel long-acting muscarinic antagonist for the treatment of obstructive airways disease.
Barnes PJ; Belvisi MG; Mak JC; Haddad EB; O'Connor B
Life Sci; 1995; 56(11-12):853-9. PubMed ID: 10188785
[TBL] [Abstract][Full Text] [Related]
14. Preclinical evaluation of long-acting muscarinic antagonists: comparison of tiotropium and investigational drugs.
Casarosa P; Bouyssou T; Germeyer S; Schnapp A; Gantner F; Pieper M
J Pharmacol Exp Ther; 2009 Aug; 330(2):660-8. PubMed ID: 19478135
[TBL] [Abstract][Full Text] [Related]
15. Pharmacological characterization of the muscarinic receptor antagonist, glycopyrrolate, in human and guinea-pig airways.
Haddad EB; Patel H; Keeling JE; Yacoub MH; Barnes PJ; Belvisi MG
Br J Pharmacol; 1999 May; 127(2):413-20. PubMed ID: 10385241
[TBL] [Abstract][Full Text] [Related]
16. Comparative characterization of lung muscarinic receptor binding after intratracheal administration of tiotropium, ipratropium, and glycopyrrolate.
Ogoda M; Niiya R; Koshika T; Yamada S
J Pharmacol Sci; 2011; 115(3):374-82. PubMed ID: 21358117
[TBL] [Abstract][Full Text] [Related]
17. An update on the efficacy and safety of aclidinium bromide in patients with COPD.
Alagha K; Bourdin A; Tummino C; Chanez P
Ther Adv Respir Dis; 2011 Feb; 5(1):19-28. PubMed ID: 20884687
[TBL] [Abstract][Full Text] [Related]
18. The safety of anticholinergic bronchodilators for the treatment of chronic obstructive pulmonary disease.
Tashkin DP
Expert Opin Drug Saf; 2015; 14(11):1759-72. PubMed ID: 26401729
[TBL] [Abstract][Full Text] [Related]
19. NVA237, a long-acting muscarinic antagonist, as an emerging therapy for chronic obstructive pulmonary disease.
Vogelmeier C; Banerji D
Ther Adv Respir Dis; 2011 Jun; 5(3):163-73. PubMed ID: 21511677
[TBL] [Abstract][Full Text] [Related]
20. Profile of aclidinium bromide in the treatment of chronic obstructive pulmonary disease.
Sims MW; Panettieri RA
Int J Chron Obstruct Pulmon Dis; 2011; 6():457-66. PubMed ID: 22003291
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
